Quantification of the pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite-asbestos following short-term inhalation exposure

References

• Agostoni E, Zocchi L. 1998. Mechanical coupling and liquid exchanges in the pleural space. Clin Chest Med 19:241–260.
   PubMedGoogle Scholar
• Antonini JM, Charron TG, Roberts JR, Lai J, Blake TL, Rogers RA. 1999. Application of laser scanning confocal microscopy in the analysis of particle-induced pulmonary fibrosis. Toxicol Sci 51:126–134.
   PubMedGoogle Scholar
• Bermudez E, Mangum JB, Moss OR, Wong BA, Everitt JI. 2003. Pleural dosimetry and pathobiological responses in rats and hamsters exposed subchronically to MMVF 10a fiberglass. Toxicol Sci 74:165–173.
   PubMed Web of Science ®Google Scholar
• Bernstein DM, Hoskins JA. 2006. The health effects of chrysotile: current perspective based upon recent data. Regul Toxicol Pharmacol 45:252–264.
   PubMed Web of Science ®Google Scholar
• Bernstein DM, Rogers R, Smith P. 2004. The biopersistence of brazilian chrysotile asbestos following inhalation. Inhal Toxicol 16:745–761.
   PubMed Web of Science ®Google Scholar
• Bernstein DM, Chevalier J, Smith P. 2005. Comparison of Calidria chrysotile asbestos to pure tremolite: final results of the inhalation biopersistence and histopathology examination following short-term exposure. Inhal Toxicol 17:427–449.
   PubMed Web of Science ®Google Scholar
• Bernstein DM, Donaldson K, Decker U, Gaering S, Kunzendorf P, Chevalier J, Holm SE. 2008. A biopersistence study following exposure to chrysotile asbestos alone or in combination with fine particles. Inhal Toxicol 20:1009–1028.
   PubMed Web of Science ®Google Scholar
• Bernstein D, Rogers R, Smith P. 2005. The biopersistence of Canadian chrysotile asbestos following inhalation: final results through 1 year after cessation of exposure. Inhal Toxicol 17:1–14.
   PubMed Web of Science ®Google Scholar
• Bernstein DM, Rogers RA, Sepulveda R, Donaldson K, Schuler D, Gaering S, Kunzendorf P, Chevalier J, Holm SE. 2010. The pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite asbestos following short-term inhalation exposure: interim results. Inhal Toxicol 22:937–962.
   PubMed Web of Science ®Google Scholar
• Brorby GP, Sheehan PJ, Berman DW, Greene JF, Holm SE. 2008. Re-creation of historical chrysotile-containing joint compounds. Inhal Toxicol 20:1043–1053.
   PubMed Web of Science ®Google Scholar
• Cannon WC, Blanton EF, McDonald KE. 1983. The flow-past chamber: an improved nose-only exposure system for rodents. Am Ind Hyg Assoc J 44:923–928.
   PubMed Web of Science ®Google Scholar
• European Commission. 1999. ECB/TM/26 rev.7. Methods for the determination of the hazardous properties for human health of man made mineral fibers (MMMF). European Commission. Joint Research search Centre, Institute for Health and Consumer Protection, Unit: Toxicology and Chemical Substances, European Chemicals Bureau.
   Google Scholar
• Fentie IH, Allen DJ, Schenck MH, Didio LJ. 1986. Comparative electron microscopic study of bovine, porcine and human parietal pericardium, as materials for cardiac valve bioprostheses. J Submicrosc Cytol 18:53–65.
   PubMedGoogle Scholar
• Hesterberg TW, Chase G, Axten C, Miller WC, Musselman RP, Kamstrup O, Hadley J, Morscheidt C, Bernstein DM, Thevenaz P. 1998. Biopersistence of synthetic vitreous fibers and amosite asbestos in the rat lung following inhalation. Toxicol Appl Pharmacol 151:262–275.
   PubMed Web of Science ®Google Scholar
• Hesterberg TW, Axten C, McConnell EE, Hart GA, Miiller W, Chevalier J, Everitt J, Thevenaz P, Oberdörster G. 1999. Studies on the inhalation toxicology of two fiberglasses and amosite asbestos in the syrian golden hamster. Part I. Results of a subchronic study and dose selection for a chronic study. Inhal Toxicol 11:747–784.
   PubMed Web of Science ®Google Scholar
• Hesterberg TW, Axten C, McConnell EE, Oberdörster G, Everitt J, Miiller WC, Chevalier J, Chase GR, Thevenaz P. 1997. Chronic inhalation study of fiber glass and amosite asbestos in hamsters: twelve-month preliminary results. Environ Health Perspect 105 Suppl 5:1223–1229.
   PubMedGoogle Scholar
• Huggins JT, Sahn SA. 2004. Causes and management of pleural fibrosis. Respirology 9:441–447.
   PubMed Web of Science ®Google Scholar
• Idell S, Mazar AP, Bitterman P, Mohla S, Harabin AL. 2001. Fibrin turnover in lung inflammation and neoplasia. Am J Respir Crit Care Med 163:578–584.
   PubMedGoogle Scholar
• Jantz MA, Antony VB. 2008. Pathophysiology of the pleura. Respiration 75:121–133.
   PubMed Web of Science ®Google Scholar
• Luoto K, Holopainen M, Kangas J, Kalliokoski P, Savolainen K. 1995. The effect of fiber length on the dissolution by macrophages of rockwool and glasswool fibers. Environ Res 70:51–61.
   PubMed Web of Science ®Google Scholar
• McConnell EE, Axten C, Hesterberg TW, Chevalier J, Miiller WC, Everitt J, Oberdörster G, Chase GR, Thevenaz P, Kotin P. 1999. Studies on the inhalation toxicology of two fiberglasses and amosite asbestos in the Syrian golden hamster. Part II. Results of chronic exposure. Inhal Toxicol 11:785–835.
   PubMed Web of Science ®Google Scholar
• Morimoto Y, Yamato H, Kido M, Tanaka I, Higashi T, Fujino A, Yokosaki Y. 1994. Effects of inhaled ceramic fibres on macrophage function of rat lungs. Occup Environ Med 51:62–67.
   PubMed Web of Science ®Google Scholar
• Muhle H, Pott F, Bellmann B, Takenaka S, Ziem U. 1987. Inhalation and injection experiments in rats to test the carcinogenicity of MMMF. Ann Occup Hyg 31:755–764.
   PubMed Web of Science ®Google Scholar
• Noppen M, De Waele M, Li R, Gucht KV, D’Haese J, Gerlo E, Vincken W. 2000. Volume and cellular content of normal pleural fluid in humans examined by pleural lavage. Am J Respir Crit Care Med 162:1023–1026.
   PubMedGoogle Scholar
• Peng MJ, Wang NS, Vargas FS, Light RW. 1994. Subclinical surface alterations of human pleura. A scanning electron microscopic study. Chest 106:351–353.
   PubMedGoogle Scholar
• Pundsack FL. 1955. The properties of asbestos. I. The colloidal and surface chemistry of chrysotile. J Phys Chem 59:892–895.
   Web of Science ®Google Scholar
• Rogers RA, Antonini JM, Brismar H, Lai J, Hesterberg TW, Oldmixon EH, Thevenaz P, Brain JD. 1999. In situ microscopic analysis of asbestos and synthetic vitreous fibers retained in hamster lungs following inhalation. Environ Health Perspect 107:367–375.
   PubMed Web of Science ®Google Scholar
• Schneider F, Sporn TA, Roggli VL. 2010. Asbestos fiber content of lungs with diffuse interstitial fibrosis: An analytical scanning electron microscopic analysis of 249 cases. Arch Pathol Lab Med 134:457–461. 2nd edn. Hodder Education: Hachette UK Company, London.
   PubMed Web of Science ®Google Scholar
• Shetty S, John J, Idell S. 2008. In Light RW, Arnold H (eds). Pleural Fibrosis. In Textbook of Pleural Diseases.
   Google Scholar
• Speil S, Leineweber JP. 1969. Asbestos minerals in modern technology. Environ Res 2:166–208.
   PubMed Web of Science ®Google Scholar
• Stoeber W, Flachsbart H, Hochrainer D. 1970. Der aerodynamische durchmesser von latexaggregaten und asbestfassern. Staub-Reinh Luft 30:277–285.
   Google Scholar
• Wypych F, Adad LB, Mattoso N, Marangon AA, Schreiner WH. 2005. Synthesis and characterization of disordered layered silica obtained by selective leaching of octahedral sheets from chrysotile and phlogopite structures. J Colloid Interface Sci 283:107–112.
   PubMed Web of Science ®Google Scholar
• Zeidler-Erdely PC, Calhoun WJ, Ameredes BT, Clark MP, Deye GJ, Baron P, Jones W, Blake T, Castranova V. 2006. In vitro cytotoxicity of Manville Code 100 glass fibers: effect of fiber length on human alveolar macrophages. Part Fibre Toxicol 3:5.
   PubMed Web of Science ®Google Scholar
• Zocchi L. 2002. Physiology and pathophysiology of pleural fluid turnover. Eur Respir J 20:1545–155.
   PubMed Web of Science ®Google Scholar